Image Guided Radiotherapy Market Share, Trends & Forecast 2034

Image Guided Radiotherapy Market Outlook

The global image-guided radiotherapy market size is expected to surge significantly and approach US$ 1.9 billion in 2024. The demand for image-guided radiotherapy is anticipated to thrive at a strong 14.7% CAGR between 2024 and 2034. The image-guided radiotherapy sales revenue is envisioned to surpass US$ 7.4 billion by 2034.

One of the main factors expected to accelerate the growth of the image-guided radiotherapy (IGRT) market is the rising incidence of cancer and the quick advancements in cancer treatment. The demand for image-guided radiation therapy (IGRT) is anticipated to be stimulated by the increasing number of older adults and cancer patients worldwide.

The IGRT market has the potential to expand due to industry improvements in technology and the increasing acceptance of various radiotherapy equipment and methods. Increased public understanding of the benefits of radiation therapy is likely to support the image-guided radiotherapy market.

Attributes	Details
Market Value for 2024	US$ 1.9 billion
Market Value for 2034	US$ 7.4 billion
Market CAGR from 2024 to 2034	14.7%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Impelling Factors Energizing the Image-guided Radiotherapy Market

The development of imaging technologies like cone-beam CT, MRI, and PET is a continuing factor in the ongoing enhancement of image-guided radiotherapy systems. These advancements compel the image-guided radiotherapy market by improving real-time tracking capabilities and image quality.
The IGRT market is expanding due to government and healthcare organization financing, initiatives, and supportive policies to enhance cancer care and treatment outcomes.
The widespread adoption of image-guided radiotherapy in clinical practice is facilitated by healthcare professionals' growing knowledge of its advantages, particularly radiation oncologists.
Many patients are looking for cutting-edge, less invasive therapy alternatives. The adoption of image-guided radiotherapy is driven by the need for therapies that provide better outcomes, decrease adverse effects, and increase precision.
Radiotherapy's overall effectiveness is increased when it can be adjusted in real-time to account for daily alterations in the architecture and position of the tumor. With the adoption of IGRT, the cancer is regularly exposed to the recommended radiation dose.

Attributes	Details
Market Value for 2019	US$ 0.9 billion
Market Value for 2023	US$ 1.6 billion
Market CAGR from 2019 to 2023	17.1%

Bottlenecks Inhibiting the Expansion of Image Guided Radiotherapy Sector

IGRT technologies and other cutting-edge healthcare facilities are typically found in developed areas. Inaccessible locations in underdeveloped nations or isolated regions are likely to contribute to differences in the outcomes of cancer treatments and impede the image-guided radiotherapy market expansion.
Companies operating in the image-guided radiotherapy industry face difficulties due to strict regulations and differences in regulatory standards among various areas. Searching complicated regulatory environments might delay getting a product approved and entering the image-guided radiation therapy (IGRT) market.
Healthcare personnel receive specialized training to adopt image-guided radiation therapy, which requires complex technology. Widespread adoption of image-guided radiotherapy is impeded by the lengthy learning curve caused by the intricacy of using and understanding data from imaging equipment.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Outlook

The segmented market analysis of image-guided radiotherapy is included in the following subsection. Based on comprehensive studies, the soft-tissue imaging sector is leading the type category, and the radiation-based segment is commanding the technology category.

Soft-tissue Imaging's Commanding Presence in Image Guided Radiotherapy Sales

Attributes	Details
Top Types	Soft-Tissue Imaging
CAGR % 2019 to 2023	16.8%
CAGR % 2024 to End of Forecast (2034)	14.5%

Soft-tissue imaging dominates image-guided radiotherapy sales because of its critical role in accurate tumor localization, making tailored radiation therapy possible.
Soft-tissue imaging provides a wide range of applications in image-guided radiotherapy, covering a broad spectrum of cancer types and guaranteeing broad commercial appeal.
The potential of soft-tissue imaging to effectively visualize anatomical features to support doctors in treatment planning and adaptation propels the demand for image-guided radiotherapy.
Soft-tissue imaging is becoming increasingly vital, strengthening its place as the main source of image-guided radiotherapy market revenue. This is due to the increased focus on customized and targeted cancer therapies.

Advancements in Radiation-Based Technology Spurring Market Preference

Attributes	Details
Top Technology	Radiation-Based
CAGR % 2019 to 2023	16.4%
CAGR % 2024 to End of Forecast (2034)	14.1%

Sustained progress in radiation-based technology guarantees a competitive advantage, propelling consumer inclination and increasing revenue.
Healthcare professionals opt for radiation-based systems because of their demonstrated efficacy and dependability.
Radiation-based methods let doctors plan adaptive treatments by offering detailed information on tumor response.
Radiation-based technologies with advanced imaging capabilities allow for real-time tumor visualization, which maximizes therapy delivery.

Country-wise Analysis

Tables highlighting important economies such as South Korea, the United Kingdom, Japan, China, and the United States demonstrate the landscape of the image-guided radiotherapy industry. The significant potential is revealed by a thorough investigation in South Korea, which offers plenty of opportunities for image-guided radiotherapy market expansion.

South Korea has an upward trajectory in the image-guided radiotherapy industry, which calls for more research and investment. These factors include technology breakthroughs, healthcare infrastructure, and regulatory frameworks.

The Rapid Integration of Image-guided Radiotherapy in South Korea

Attribute	South Korea
HCAGR (2019 to 2023)	22.3%
CAGR (2024 to 2034)	16.6%

Increasing awareness of precision treatment and an improved healthcare infrastructure have led to a growing pattern of image-guided radiotherapy adoption in South Korea.
South Korea image-guided radiation therapy market is expected to reach US$ 465.4 million by 2034.
Government programs in South Korea facilitate the rapid adoption of image-guided radiotherapy into oncology procedures that highlight technological improvements in cancer care.
The adoption of image-guided radiotherapy is motivated by the considerable emphasis on medical tourism in South Korea, which draws patients seeking advanced oncological therapies.

Image-guided Radiotherapy Enhances Cancer Treatment Quality in the United Kingdom

Attribute	United Kingdom
HCAGR (2019 to 2023)	19.6%
CAGR (2024 to 2034)	15.7%

Driven by a holistic approach to cancer treatment innovation, the United Kingdom is at the forefront of incorporating image-guided radiotherapy into its healthcare system.
By 2034, the image-guided radiotherapy market in the United Kingdom is likely to be worth US$ 294 million.
The adoption of image-guided radiotherapy is a top priority in the United Kingdom's national health policies to improve the effectiveness and caliber of cancer care services.
The broad acceptance of image-guided radiation therapy, which emphasizes individualized and precise treatment plans, is a reflection of the United Kingdom's dedication to lowering cancer deaths.

Image-guided Radiotherapy's Role in Japan's Oncology Landscape

Attribute	Japan
HCAGR (2019 to 2023)	19.3%
CAGR (2024 to 2034)	15.5%

The demand for image-guided radiotherapy in delivering focused and effective oncological therapies is highlighted by Japan's aging population and rising cancer rate.
The rigorous planning and execution of image-guided radiotherapy ensure the best treatment outcomes for patients, which aligns with the Japanese culture's emphasis on precision and attention to detail.
By 2034, the demand for image-guided radiotherapy in Japan is anticipated to be estimated at US$ 755.3 million.
Innovative medical technology is embraced by the Japanese regulatory environment, which accelerates the adoption of image-guided radiotherapy treatments.

China's Accelerated Adoption of Image-guided Radiotherapy

Attribute	China
HCAGR (2019 to 2023)	18.9%
CAGR (2024 to 2034)	15.1%

Image-guided radiotherapy adoption is increasing in China, owing to the government's emphasis on improving healthcare infrastructure and enhancing cancer treatment capabilities.
China's demand for image-guided radiotherapy is forecasted to climb to US$ 1.1 billion by 2034.
Rapid urbanization in China raises awareness and opportunities for image-guided radiotherapy, particularly in big cities with established healthcare facilities.
China's dedication to treating cancer's rising prevalence coincides with the broad adoption of image-guided radiotherapy, which provides a critical tool for accurate and effective cancer treatment.

Image-Guided Radiotherapy's Evolutionary Journey in the United States

Attribute	United States
HCAGR (2019 to 2023)	17.6%
CAGR (2024 to 2034)	14.9%

The United States is recognized as a global leader in cancer care innovation due to its strong ecosystem of research and development that fosters the ongoing advancement of image-guided radiotherapy.
The image-guided radiotherapy market in the United States is scheduled to be worth about US$ 1.3 billion by 2034.
To maximize results, the healthcare system in the United States strongly emphasizes individualized treatment programs, with image-guided radiotherapy as a key component.
Image-guided radiotherapy technologies are advancing quickly due to vendor rivalry and innovation fueled by strict regulatory standards and a competitive healthcare industry.

Competitive Analysis

Numerous significant image-guided radiotherapy (IGRT) vendors stand out as essential contributors to innovation and development in the highly competitive market. Prominent image-guided radiotherapy suppliers leading the way include ViewRay, General Electric Company, Hitachi, Ltd., Siemens AG, and Koninklijke Philips N.V.

The image-guided radiotherapy providers have come to be recognized as industry leaders, advancing the development of image-guided radiotherapy technology and establishing the bar for dependability and creativity.

With its advanced offerings, ViewRay faces against General Electric Company, a well-established leader recognized for its proficiency in medical imaging technologies. Hitachi, Ltd. offers the market a wealth of knowledge and technological know-how, while Siemens AG and Koninklijke Philips N.V. provide their creative solutions for image-guided radiotherapy.

The substantial image-guided radiotherapy vendors contribute to the continuous advancement of IGRT technology by bringing unique skills and capacities to the competition scene. They ensure that the image-guided radiotherapy (IGRT) market remains competitive and dynamic by investing in research and development and being dedicated to fulfilling the changing demands of patients and healthcare professionals.

By establishing their status as leading image-guided radiotherapy (IGRT) providers, the industry leaders are navigating the market challenges and setting the path for ongoing technological and patient care breakthroughs.

Notable Breakthroughs

Company	Details
Philips	Philips launched Zenition 10 in May 2023, adding to their line of mobile C-arms.
GE HealthCare	The introduction of Pixxoscan in April 2023 marked a portfolio expansion for GE HealthCare's magnetic resonance imaging (MRI) contrast agents. Clariscan (gadoteric acid) and Pixxoscan (gadobutrol), two of many prominent macrocyclic compounds, are accessible to customers.
GE HealthCare	GE HealthCare revealed plans in June 2023 to integrate AIR technology into its PET/MR capabilities to enhance patient comfort, simplify therapy evaluation, and increase diagnostic accuracy.
National Medical Products Administration (NMPA)	ViewRay's MRIdian MRI-guided radiation therapy system was authorized for sale and usage in September 2022 by the National Medical Products Administration (NMPA), China's regulatory body.

Vital Image Guided Radiotherapy Providers

ViewRay
General Electric Company
Hitachi, Ltd.
Siemens AG
Koninklijke Philips N.V.

Key Coverage in Image Guided Radiotherapy Market Report

Categorical Study on Radiation-Based, and Non-Radiation Based Systems
Image Guided Radiotherapy Market Detailed Analysis of Current Scenario with Growth Forecasts
Market Opportunities for Image Guided Radiotherapy is South Korea
Market Potential of Image Guided Radiotherapy in the United Kingdom
Competition Analysis of Image Guided Radiotherapy Industry with Focus on Philips, and GE HealthCare

Key Segments

By Type:

Soft-Tissue Imaging
Lung Mri
Simplifying Cardiac Mri
Simplifying Mri-Conditional Implant Scans
Silent Mri Scanning

By Technology:

Radiation-Based
Non-Radiation Based Systems

By Devices:

X-Ray Computed Tomography (Ct)
Magnetic Resonance Imaging (Mri)
Positron Emission Tomography

By End Users:

Hospitals
Smart Cancer Centers
Research Institutes

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Frequently Asked Questions

What is Current Image Guided Radiotherapy Market Valuation?

The image guided radiation therapy market to secure a valuation US$ 1.9 billion in 2024.

How Big Can the Image Guided Radiotherapy Market Be by 2034?

The image guided radiation therapy market is estimated to attain a worth of US$ 7.4 billion by 2034.

What is the Growth Potential of the Image Guided Radiotherapy Market?

Through 2034, the image guided radiation therapy market is anticipated to strengthen at a 14.7% CAGR.

What Was the Historical Outlook of The Image Guided Radiotherapy Market?

From 2019 to 2023, the image guided radiation therapy market recorded a 17.1% CAGR.

Which Types Segment to Dominate in the Image Guided Radiotherapy Market?

From 2024 to 2034, the soft-tissue imaging sector is projected to flourish at a 14.5% CAGR.

Which Technology Segment to Lead the Image Guided Radiotherapy Market?

The radiation-based sector is envisioned to develop at a 14.1% CAGR from 2024 to 2034.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034

5.3.1. Soft-Tissue Imaging

5.3.2. Lung Mri

5.3.3. Simplifying Cardiac Mri

5.3.4. Simplifying Mri-Conditional Implant Scans

5.3.5. Silent Mri Scanning

5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034

6.3.1. Radiation-Based

6.3.2. Non-Radiation Based Systems

6.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Devices

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By Devices, 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Devices, 2024 to 2034

7.3.1. X-Ray Computed Tomography (Ct)

7.3.2. Magnetic Resonance Imaging (Mri)

7.3.3. Positron Emission Tomography

7.4. Y-o-Y Growth Trend Analysis By Devices, 2019 to 2023

7.5. Absolute $ Opportunity Analysis By Devices, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Users

8.1. Introduction / Key Findings

8.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2019 to 2023

8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2024 to 2034

8.3.1. Hospitals

8.3.2. Smart Cancer Centers

8.3.3. Research Institutes

8.4. Y-o-Y Growth Trend Analysis By End Users, 2019 to 2023

8.5. Absolute $ Opportunity Analysis By End Users, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

9.1. Introduction

9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

9.3.1. North America

9.3.2. Latin America

9.3.3. Western Europe

9.3.4. Eastern Europe

9.3.5. South Asia and Pacific

9.3.6. East Asia

9.3.7. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. USA

10.2.1.2. Canada

10.2.2. By Type

10.2.3. By Technology

10.2.4. By Devices

10.2.5. By End Users

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Type

10.3.3. By Technology

10.3.4. By Devices

10.3.5. By End Users

10.4. Key Takeaways

11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Brazil

11.2.1.2. Mexico

11.2.1.3. Rest of Latin America

11.2.2. By Type

11.2.3. By Technology

11.2.4. By Devices

11.2.5. By End Users

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Type

11.3.3. By Technology

11.3.4. By Devices

11.3.5. By End Users

11.4. Key Takeaways

12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Germany

12.2.1.2. UK

12.2.1.3. France

12.2.1.4. Spain

12.2.1.5. Italy

12.2.1.6. Rest of Western Europe

12.2.2. By Type

12.2.3. By Technology

12.2.4. By Devices

12.2.5. By End Users

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Type

12.3.3. By Technology

12.3.4. By Devices

12.3.5. By End Users

12.4. Key Takeaways

13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. Poland

13.2.1.2. Russia

13.2.1.3. Czech Republic

13.2.1.4. Romania

13.2.1.5. Rest of Eastern Europe

13.2.2. By Type

13.2.3. By Technology

13.2.4. By Devices

13.2.5. By End Users

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Type

13.3.3. By Technology

13.3.4. By Devices

13.3.5. By End Users

13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. India

14.2.1.2. Bangladesh

14.2.1.3. Australia

14.2.1.4. New Zealand

14.2.1.5. Rest of South Asia and Pacific

14.2.2. By Type

14.2.3. By Technology

14.2.4. By Devices

14.2.5. By End Users

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Type

14.3.3. By Technology

14.3.4. By Devices

14.3.5. By End Users

14.4. Key Takeaways

15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. China

15.2.1.2. Japan

15.2.1.3. South Korea

15.2.2. By Type

15.2.3. By Technology

15.2.4. By Devices

15.2.5. By End Users

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Type

15.3.3. By Technology

15.3.4. By Devices

15.3.5. By End Users

15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

16.2.1. By Country

16.2.1.1. GCC Countries

16.2.1.2. South Africa

16.2.1.3. Israel

16.2.1.4. Rest of MEA

16.2.2. By Type

16.2.3. By Technology

16.2.4. By Devices

16.2.5. By End Users

16.3. Market Attractiveness Analysis

16.3.1. By Country

16.3.2. By Type

16.3.3. By Technology

16.3.4. By Devices

16.3.5. By End Users

16.4. Key Takeaways

17. Key Countries Market Analysis

17.1. USA

17.1.1. Pricing Analysis

17.1.2. Market Share Analysis, 2023

17.1.2.1. By Type

17.1.2.2. By Technology

17.1.2.3. By Devices

17.1.2.4. By End Users

17.2. Canada

17.2.1. Pricing Analysis

17.2.2. Market Share Analysis, 2023

17.2.2.1. By Type

17.2.2.2. By Technology

17.2.2.3. By Devices

17.2.2.4. By End Users

17.3. Brazil

17.3.1. Pricing Analysis

17.3.2. Market Share Analysis, 2023

17.3.2.1. By Type

17.3.2.2. By Technology

17.3.2.3. By Devices

17.3.2.4. By End Users

17.4. Mexico

17.4.1. Pricing Analysis

17.4.2. Market Share Analysis, 2023

17.4.2.1. By Type

17.4.2.2. By Technology

17.4.2.3. By Devices

17.4.2.4. By End Users

17.5. Germany

17.5.1. Pricing Analysis

17.5.2. Market Share Analysis, 2023

17.5.2.1. By Type

17.5.2.2. By Technology

17.5.2.3. By Devices

17.5.2.4. By End Users

17.6. UK

17.6.1. Pricing Analysis

17.6.2. Market Share Analysis, 2023

17.6.2.1. By Type

17.6.2.2. By Technology

17.6.2.3. By Devices

17.6.2.4. By End Users

17.7. France

17.7.1. Pricing Analysis

17.7.2. Market Share Analysis, 2023

17.7.2.1. By Type

17.7.2.2. By Technology

17.7.2.3. By Devices

17.7.2.4. By End Users

17.8. Spain

17.8.1. Pricing Analysis

17.8.2. Market Share Analysis, 2023

17.8.2.1. By Type

17.8.2.2. By Technology

17.8.2.3. By Devices

17.8.2.4. By End Users

17.9. Italy

17.9.1. Pricing Analysis

17.9.2. Market Share Analysis, 2023

17.9.2.1. By Type

17.9.2.2. By Technology

17.9.2.3. By Devices

17.9.2.4. By End Users

17.10. Poland

17.10.1. Pricing Analysis

17.10.2. Market Share Analysis, 2023

17.10.2.1. By Type

17.10.2.2. By Technology

17.10.2.3. By Devices

17.10.2.4. By End Users

17.11. Russia

17.11.1. Pricing Analysis

17.11.2. Market Share Analysis, 2023

17.11.2.1. By Type

17.11.2.2. By Technology

17.11.2.3. By Devices

17.11.2.4. By End Users

17.12. Czech Republic

17.12.1. Pricing Analysis

17.12.2. Market Share Analysis, 2023

17.12.2.1. By Type

17.12.2.2. By Technology

17.12.2.3. By Devices

17.12.2.4. By End Users

17.13. Romania

17.13.1. Pricing Analysis

17.13.2. Market Share Analysis, 2023

17.13.2.1. By Type

17.13.2.2. By Technology

17.13.2.3. By Devices

17.13.2.4. By End Users

17.14. India

17.14.1. Pricing Analysis

17.14.2. Market Share Analysis, 2023

17.14.2.1. By Type

17.14.2.2. By Technology

17.14.2.3. By Devices

17.14.2.4. By End Users

17.15. Bangladesh

17.15.1. Pricing Analysis

17.15.2. Market Share Analysis, 2023

17.15.2.1. By Type

17.15.2.2. By Technology

17.15.2.3. By Devices

17.15.2.4. By End Users

17.16. Australia

17.16.1. Pricing Analysis

17.16.2. Market Share Analysis, 2023

17.16.2.1. By Type

17.16.2.2. By Technology

17.16.2.3. By Devices

17.16.2.4. By End Users

17.17. New Zealand

17.17.1. Pricing Analysis

17.17.2. Market Share Analysis, 2023

17.17.2.1. By Type

17.17.2.2. By Technology

17.17.2.3. By Devices

17.17.2.4. By End Users

17.18. China

17.18.1. Pricing Analysis

17.18.2. Market Share Analysis, 2023

17.18.2.1. By Type

17.18.2.2. By Technology

17.18.2.3. By Devices

17.18.2.4. By End Users

17.19. Japan

17.19.1. Pricing Analysis

17.19.2. Market Share Analysis, 2023

17.19.2.1. By Type

17.19.2.2. By Technology

17.19.2.3. By Devices

17.19.2.4. By End Users

17.20. South Korea

17.20.1. Pricing Analysis

17.20.2. Market Share Analysis, 2023

17.20.2.1. By Type

17.20.2.2. By Technology

17.20.2.3. By Devices

17.20.2.4. By End Users

17.21. GCC Countries

17.21.1. Pricing Analysis

17.21.2. Market Share Analysis, 2023

17.21.2.1. By Type

17.21.2.2. By Technology

17.21.2.3. By Devices

17.21.2.4. By End Users

17.22. South Africa

17.22.1. Pricing Analysis

17.22.2. Market Share Analysis, 2023

17.22.2.1. By Type

17.22.2.2. By Technology

17.22.2.3. By Devices

17.22.2.4. By End Users

17.23. Israel

17.23.1. Pricing Analysis

17.23.2. Market Share Analysis, 2023

17.23.2.1. By Type

17.23.2.2. By Technology

17.23.2.3. By Devices

17.23.2.4. By End Users

18. Market Structure Analysis

18.1. Competition Dashboard

18.2. Competition Benchmarking

18.3. Market Share Analysis of Top Players

18.3.1. By Regional

18.3.2. By Type

18.3.3. By Technology

18.3.4. By Devices

18.3.5. By End Users

19. Competition Analysis

19.1. Competition Deep Dive

19.1.1. ViewRay

19.1.1.1. Overview

19.1.1.2. Product Portfolio

19.1.1.3. Profitability by Market Segments

19.1.1.4. Sales Footprint

19.1.1.5. Strategy Overview

19.1.1.5.1. Marketing Strategy

19.1.2. General Electric Company

19.1.2.1. Overview

19.1.2.2. Product Portfolio

19.1.2.3. Profitability by Market Segments

19.1.2.4. Sales Footprint

19.1.2.5. Strategy Overview

19.1.2.5.1. Marketing Strategy

19.1.3. Hitachi, Ltd

19.1.3.1. Overview

19.1.3.2. Product Portfolio

19.1.3.3. Profitability by Market Segments

19.1.3.4. Sales Footprint

19.1.3.5. Strategy Overview

19.1.3.5.1. Marketing Strategy

19.1.4. Siemens AG

19.1.4.1. Overview

19.1.4.2. Product Portfolio

19.1.4.3. Profitability by Market Segments

19.1.4.4. Sales Footprint

19.1.4.5. Strategy Overview

19.1.4.5.1. Marketing Strategy

19.1.5. Koninklijke Philips N.V.

19.1.5.1. Overview

19.1.5.2. Product Portfolio

19.1.5.3. Profitability by Market Segments

19.1.5.4. Sales Footprint

19.1.5.5. Strategy Overview

19.1.5.5.1. Marketing Strategy

19.1.6. TOSHIBA CORPORATION

19.1.6.1. Overview

19.1.6.2. Product Portfolio

19.1.6.3. Profitability by Market Segments

19.1.6.4. Sales Footprint

19.1.6.5. Strategy Overview

19.1.6.5.1. Marketing Strategy

19.1.7. Varian Medical Systems, Inc

19.1.7.1. Overview

19.1.7.2. Product Portfolio

19.1.7.3. Profitability by Market Segments

19.1.7.4. Sales Footprint

19.1.7.5. Strategy Overview

19.1.7.5.1. Marketing Strategy

19.1.8. Vision RT Ltd.

19.1.8.1. Overview

19.1.8.2. Product Portfolio

19.1.8.3. Profitability by Market Segments

19.1.8.4. Sales Footprint

19.1.8.5. Strategy Overview

19.1.8.5.1. Marketing Strategy

19.1.9. Scranton Gillette Communications

19.1.9.1. Overview

19.1.9.2. Product Portfolio

19.1.9.3. Profitability by Market Segments

19.1.9.4. Sales Footprint

19.1.9.5. Strategy Overview

19.1.9.5.1. Marketing Strategy

19.1.10. XinRay Systems

19.1.10.1. Overview

19.1.10.2. Product Portfolio

19.1.10.3. Profitability by Market Segments

19.1.10.4. Sales Footprint

19.1.10.5. Strategy Overview

19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Image Guided Radiotherapy Market

Image Guided Radiotherapy Market Forecast by Radiation-based, and Non-radiation Based Systems through 2034